Characteristics and outcome of B-cell chronic lymphocytic leukemia in hepatitis C virus-positive patients [6]

Leukemia and Lymphoma

Volumn 47, Issue 11, 2006, Pages 2421-2423

  Molica, Stefano ^a   Mirabelli, Rosanna ^a   Misuraca, Demetrio ^a  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CD38 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; GANCICLOVIR; HEMOGLOBIN; HEPATITIS C ANTIBODY; PROTEIN KINASE ZAP 70;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; B CELL LEUKEMIA; B CELL LYMPHOMA; BLADDER CANCER; BONE MARROW BIOPSY; BREAST CANCER; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HASHIMOTO DISEASE; HEMOGLOBIN DETERMINATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; KAPOSI SARCOMA; LETTER; LIVER TOXICITY; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; SEX RATIO; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33751085618     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600834412     Document Type: Letter

References (9)

1. Zuckerman, E and Zuckerman, T and Levine, A and Douer, D and Gutekunst, K and Mizokami, M and (1997) Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma Ann Intern Med, 127, pp. 423-428.
2. Ferri, C and Caracciolo, F and Zignego, A and La Civita, L and Monti, M and Longombardo, G and (1994) Hepatitis C virus infection in patients with non-Hodgkin's lymphoma Br J Haematol, 88, pp. 392-394.
3. Mele, A and Pulsoni, A and Bianco, E and Musto, P and Szklo, A and Sanpaolo, M and (2003) Hepatitis C virus and B-cell non-Hodgkin lymphomas: An Italian multi-center case-control study Blood, 102, pp. 996-999.
4. Negri, E and Little, D and Boiocchi, M and La Vecchia, C and Franceschi, S. (2004) B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review Int J Cancer, 111, pp. 1-8.
5. Gisbert, J and Garcia-Buey, L and Pajares, J and Moreno-Otero, R. (2003) Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: Systematic review and meta-analysis Gastroenterology, 125, pp. 1723-1732.
6. Besson, C and Canioni, D and Lepage, D and Pol, S and Morel, P and Lederlin, P and (2006) Characteristics and outcome of diffuse B-cell lymphoma in hepatitis C-virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adult programs J Clin Oncol, 24, pp. 953-960.
7. Hamblin, T. (2006) Autoimmune complications of chronic lymphocytic leukemia Semin Oncol, 33, pp. 230-239.
8. Tsutsumi, Y and Kanamori, H and Mori, A and Tanaka, J and Asaka, M and Imamura, M and Masauzi, N. (2005) Reactivation of hepatitis B virus with rituximab Expert Opin Drug Saf, 4, pp. 599-608.
9. Caligaris-Cappio, F and De Leo, A and Bertero, M. (1997) Autoimmune phenomena and hepatitis C virus in lymphoproliferative and connective tissue disorders Leuk Lymphoma, 28, pp. 57-63.